Assessment of Body Composition in Patients with Multiple Sclerosis: Institutional-Based Cross-Sectional Study

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages:
Authors:
Journal: The Egyptian Journal of Hospital Medicine The Egyptian Journal of Hospital Medicine Volume:
Keywords : Assessment , Body Composition , Patients with Multiple    
Abstract:
Background: Multiple sclerosis (MS) is the most common progressive neurologic disease all over the world. MS is an immune-mediated disease and there is contradictory data regarding cardiovascular morbidity and mortality risk factors in MS patients. Objective: To assess the body composition in MS patients, and to explore the associations of anthropometric indices and metabolic risk factors with the phenotypic features of MS. Patients and Methods: a cross-sectional study included 150 patients fulfilling the diagnostic criteria for MS according to the revised McDonald’s criteria 2010, and 145 age and sex-matched healthy controls. Fat mass index (FMI) and free fat mass index (FFMI) were assessed by dual-energy X-Ray absorptiometry (DEXA). Results: This study was conducted on MS patients with phenotypes; RRMS (82%) and SPMS (18%). our results revealed that the distribution of body composition among MS patients was 30 %, overweight was 48% and lean was 22%. Also, MS patients had significantly higher values of systolic and diastolic blood pressure as well as dyslipidemia, obesity indices, and hs-CRP compared to the control group, P-value < 0.001. Interestingly, there were significantly higher values of the expanded disability status scale (EDSS), dyslipidemia, obesity indices, and hypertension in the obese group compared to other groups. Conclusions: MS patients had higher values of dyslipidemia and obesity indices than control groups. Among MS, the prevalence of overweight patients was higher than lean and obese MS patients. Keywords: Multiple sclerosis, Body composition, EDSS, FM
   
     
 
       

Author Related Publications

  • Nearmeen Mohammed Rashad Ahmmad, "Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis", wiley, 2021 More
  • Nearmeen Mohammed Rashad Ahmmad, "The diagnostic significance of circulating lncRNA ADAMTS9-AS2 tumor biomarker in non-small cell lung cancer among the Egyptian population", wiley, 2021 More
  • Nearmeen Mohammed Rashad Ahmmad, "Osteoprotegerin expression and serum values in obese women with type 2 diabetes mellitus", springer, 2021 More
  • Nearmeen Mohammed Rashad Ahmmad, "nterferon-gamma Expression Profile as Diagnostic Signatures of Unexplained Infertility in Female Patients Suffer from Hashimoto's Thyroiditis", Tehran University of Medical Sciences, 2021 More
  • Nearmeen Mohammed Rashad Ahmmad, "Association of miRNA − 320 expression level and its target gene endothelin-1 with the susceptibility and clinical features of polycystic ovary syndrome", BMC, 2019 More

Department Related Publications

  • Nermin Saad Abdel Moneim, "Effect of rifaximin in the prevention of acute kidney injury and hepatorenal syndrome type II in Egyptian HCV cirrhotic patients تأثير الريفاكسيمين في الوقاية من إصابة الكلى الحادة ومتلازمة الكبد الكلوية من النوع الثاني لدى مرضى تليف الكبد بفيروس التهاب الكبد الوبائي سي المصريين في الخلايا الليمفاوية", Zagazig University Medical Journal, 2021 More
  • Mohammed Srour Mohammed Muhammed, "Ascitic Calprotectin as an early predictor of hepatocellular carcinoma in patients with cirrhotic ascites", SPRINGER, 2020 More
  • Nafisa Mohamed KamalElDin, "Vitamin D Pattern in Patients with Systemic Lupus Erythematosus with and without Nephritis", international, 2021 More
  • Azza Hassan AbdelFattah, "Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients عامل نمو الخلايا الليفية 21 , 23 كمؤشرات حيوية لاعتلال الكلى السكري في مراحله المبكرة لدى مرضى السكري من النوع الثاني", Zagazig University Medical Journal, 2024 More
  • Ahmed Shehata Mostafa Embaby, "Prognostic values of myeloid differentiation factor 88 (MYD88) and transducin (β)-like receptor 1 (TBLR1) expression in tissues of diffuse large B-cell non-Hodgkin lymphoma patients - an immunohistochemical study.", Termedia Publishing House Ltd, 2022 More
Tweet